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Introdução: Em Portugal, a doença pulmonar obstructiva 
crónica (DPOC) afeta 14,2% daqueles com mais de 40 
anos. A Medicina Interna tem um papel nos cuidados da 
exacerbação de DPOC hospitalizada. O nosso objetivo 
foi caracterizar as admissões por DPOC exacerbada num 
Serviço de Medicina Interna focando os preditores de mau 
prognóstico. 
Métodos:	Um	estudo	observacional	retrospectivo	recolheu	
dados de três anos consecutivos. Para a análise univariada 
e multivariada foi assumido o evento morte intra-hospitalar 
por qualquer causa. 
Resultados: A amostra integrou 280 casos. A média das 
idades foi de 76,0 anos e 53,6% eram homens. À admis-
são, a depressão do estado de consciência foi evidente 
em 21,8% e hipotensão em 3,6%. Detectou-se acidemia 
em 36% e hipercapnia em 64,3%. Hemoglobina abaixo de 
10,0	g/dL	verificou-se	em	4,6%,	eosinopenia	em	20,4%,	e	
creatininemia	superior	a	2,0	mg/dL	em	6,0%.	Dez	porcento	
tinham	 fibrilhação	 auricular.	 Vinte	 e	 nove	doentes	 falece-
ram	 no	 hospital	 (10,4%).	 Identificámos	 os	 seguintes	 pre-
ditores:	admissão	nos	90	dias	prévios	(OR	4,7;	p = 0,006), 
fibrilhação	auricular	(OR	5,0;	p = 0,002), pressão sistólica 
< 100 mm Hg (OR 3,7; p = 0,023), eosinopenia (OR 2,7; 
p = 0,034), anemia (OR 5,1; p = 0,026) e disfunção renal 
(OR 3,8; p = 0,048). A ausência de preditores na admissão 
correspondeu	a	um	perfil	de	baixo	risco.	
Conclusão: Comparado com a generalidade dos doentes 
com exacerbação com DPOC, aqueles admitidos num Ser-
viço de Medicina Interna tendem a ser mais idosos e a ter 
mais	comorbilidades.	Os	preditores	identificados	têm	rela-
ção	com	a	fisiopatologia	da	exacerbação	da	DPOC.
Palavra-chave:	 Doença	 Pulmonar	 Obstructiva	 Crónica/
complicações; Hospitalização; Medicina Interna; Prognós-
tico. 
Abstract
Introduction: In Portugal, chronic obstructive pulmonary 
disease (COPD) affects around 14.2% of those older than 
40 years. Internal Medicine plays a role in the hospital-
ized CODP exacerbation patient care. Our objective was 
to characterize the COPD exacerbation patients admitted 
to an Internal Medicine ward focusing on adverse outcome 
predictors. 
Methods: An observational retrospective study retrieved 
data from three consecutive years. A univariate and mul-
tivariate analysis was performed assuming the all-cause 
in-hospital death outcome. 
Results: The sample comprised 280 cases. The mean age 
was 76.0 years and 53.6% were male. At admission, de-
pressed mental status was evident in 21.8% and hypoten-
sion in 3.6%. Thirty six percent were acidemic and 64.3% 
were hypercapnic. A hemoglobin value below 10.0 g/dL 
was found in 4.6%, eosinopenia in 20.4%, and creatinine-
mia above 2.0 mg/dL in 6.0%. Ten percent had atrial fibril-
lation. Twenty-nine patients died in the hospital (10.4%). We 
identified the following predictors: admission in the previ-
ous 90 days (OR 4.7; p = 0.006), atrial fibrillation (OR 5.0; p 
= 0.002), systolic blood pressure < 100 mm Hg (OR 3.7; p 
= 0.023), eosinopenia (OR 2.7; p = 0.034) and hemoglobin 
< 10 g/dL (OR 5.1; p = 0.026) and creatinine > 2.0 mg/dL 
(OR 3.8; p = 0.048). Absence of predictors at admission 
was linked to a low risk profile. 
Conclusion: Compared to the overall COPD exacerbation 
patient, those admitted to an Internal Medicine tend to be 
older and to have higher degree of comorbidity. The iden-
tified predictors can be linked to the COPD exacerbation 
pathophysiology.
Keywords: Hospitalization; Internal Medicine; Prognosis; 
Pulmonary Disease, Chronic Obstructive/complications.
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tics (active or past smoking habits, spirometric results, last 
spirometry date) prior to the admission were taken. Clinical 
status and complementary exam results at the admission 
were collected. The clinical status contained Glasgow 
coma scale, systolic blood pressure, heart rate, respiratory 
rate, and temperature. The selection of parameters from 
arterial blood gasimetry, hemogram and biochemical study 
was based on the readiness in our emergency room and 
on the clinical relevance reported in the consulted litera-
ture.3-5 Parameters with more than 5% of missing values 
were excluded from the analysis. Depressed mental status 
was	defined	as	Glasgow	coma	scale	inferior	to	15	points.	
Hypotension	 was	 defined	 systolic	 blood	 pressure	 lower	
than	90	mm	Hg.	Acidemia	was	defined	as	arterial	pH	lower	
than 7.35 and hypercapnia as arterial pCO2 higher than 45 
mm Hg. Eosinophil count inferior to 0.5 x 109/L	denoted	eo-
sinopenia.	The	diagnosis	of	atrial	fibrillation	(AF)	required	
documentation on 12-lead electrocardiogram at the time of 
hospital admission. Further data concerning the in-hospi-
tal therapy (pharmacologic therapy, mechanical ventilation 
need) or and clinical outcomes (complications, intensive 
care unit admission, and all-cause in-hospital death) were 
also assessed. The characterization of the patient sample 
included proportions (count and relative frequency), and 
means with standard deviation.
A comparison of variables between the survivor to dis-
charge and deceased in hospital groups was performed. 
After assuring normality status with Shapiro-Wilk test, in-
dependent sample Student t or Welch-Satterthaite test, 
according to Levene’s test for equality of variance, were 
used to compare the continuous variable means. For cate-
gorical variables we used Fisher exact test. To assess the 
predictive factors, we selected parameters with differenc-
es between groups according to a p value below 0.10 cri-
terion. This maximizes the selection of potential predictors 
and parallels previous studies with similar methodology.5 
Variables were reformatted to dichotomic type using cut-
off	points	 identified	according	 to:	visual	 inspection	of	 the	
receiver operator characteristic (ROC) curve; a clinically 
relevant value; a mean. Then a binary logistic regression 
model for the in-hospital death outcome was elaborated. 
The	final	model	performance	was	evaluated	by	measuring	
the	 area	 under	 predicted	 probability	 versus	 verified	 out-
come ROC curve, model Nagelkerk R2 and Hosmer and 
Lemeshow	goodness-of-fit	test	Χ2.
Finally, patients were distributed according to number of 
predictive factors to assess the effect of cumulative pres-
ence on group mortality.
All data was accessed only by the authors using the insti-
tution electronic process application. The statistical analy-
sis was performed using IBM SPSS® version 19. A p value 
below 0.05 was assumed as statistically reliable.
Introduction
Chronic obstructive pulmonary disease (COPD) is a res-
piratory	 disease	 responsible	 for	 a	 significant	 decline	 in	
life	 expectancy	 and	quality	 of	 life	 of	 those	 afflicted	by	 it.	
In Portugal, it affects 14.2% of those older than 40 years. 
In 2013, the number of hospital admission derived from 
COPD was 8361 and the in-hospital mortality was 7.4%.1 
Exacerbations of COPD are recognized as important 
events	 in	 the	natural	disease	course:	repeated	exacerba-
tions accelerate the disease progression, lead to quality 
of life deterioration and, when associated with ventilatory 
failure, to premature death.2 The approach to COPD exac-
erbation patient includes therapy prescription and health 
care resources allocation according to severity.3 Outcome 
predictors	specific	for	COPD	exacerbation	were	identified	
in the critical care context.4 Another study found a differ-
ent set of outcome predictors (like acidemia, eosinopenia 
and	atrial	 fibrillation)	but	 excluded	patients	who	 required	
long	term	domiciliary	ventilation	or	afflicted	by	considera-
ble survival-limiting comorbidities.5 In our daily practice in 
an Internal Medicine ward, we often deal with patients in 
these circumstances adding those with high degree of de-
pendence. These facts may shift the COPD exacerbation 
profile	in	our	wards	from	that	found	in	Pulmonology	wards,	
respiratory care, and critical care units. This study aims to 
characterize the admissions caused by acute exacerba-
tions of COPD in an Internal Medicine ward, and, second-
arily, to identify parameters known at the time of admission 
associated with in-hospital outcome.
Methods
In order to achieve that objective, an observational ret-
rospective study was designed and the institution ethics 
committee approval was obtained. Clinical records from 
consecutive admissions to an Internal Medicine ward be-
tween January 2011 and December 2013 were reviewed. 
The	inclusion	criteria	were:	clinical	diagnosis	by	the	attend-
ing physician of acute exacerbation of COPD leading to 
hospital admission; admission from the community; pre-
vious diagnosis of COPD supported by spirometric evi-
dence	 (forced	 expiratory	 volume	 in	 first	 second	 /	 forced	
vital	 capacity	 ratio	 lower	 than	0.70	without	 significant	 im-
provement after bronchodilation) when clinically stable; 
patient age equal or superior than 18 years. The exclusion 
criteria	 were:	 concurrent	 diagnosis	 at	 admission	 (includ-
ing stroke, acute heart failure, acute coronary syndrome, 
pulmonary embolism, and thoracic trauma) based on at-
tending	 physician	 judgment	 and/or	 confirmatory	 exams.	
Patients with comorbidities expected to limit survival at 12 
months,	submitted	to	domiciliary	oxygen/ventilation	or	hav-
ing	 ‘do-not-intubate’	 order	 were	 not	 excluded.	 Socio-de-
mographic (gender, age) and COPD-related characteris-
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Table 1: Characteristics description of the patient sample, and comparison between survivor and deceased groups 






t test (df) p value† 
n = 280 n = 251 n = 29
Background 
Male 150 (53.6%) 134 (53.4%) 16 (55.2%) - 0.507
Age (years) 76.0 ± 10.0 75.5 ± 10.6 80.8 ± 6.8 -3.7 (45.5)‡ 0.001
Charlson index 5.0 ± 1.2 4.9 ± 0.9 5.2 ± 1.7 1.5 (278)§ 0.131
Cerebrovascular disease 78 (27.8%) 69 (27.5%) 9 (31.0%) - 0.691
Ischemic heart disease 77 (27.5%) 67 (26.7%) 10 (34.4%) - 0.400
Arterial hypertension 115 (41.1%) 102 (40.6%) 13 (44.8%) - 0.663
Diabetes mellitus 46 (16.4%) 41 (16.3%) 5 (17.2%) - 0.901
Chronic kidney disease 39 (13.9%) 34 (13.5%) 5 (17.2%) - 0.586
Cognitive impairment 36 (9.3%) 32 (12.7%) 4 (13.7%) - 0.879
Active or past smoking habits 100 (35.7%) 89 (35.5%) 11 (37.9%) - 0.471
Admission in the previous 90 days 26 (9.3%) 19 (7.6%) 7 (24.1%) - 0.010
FEV1 (% predicted) 53.6 ± 17.0 53.4 ± 16.5 54.4 ± 17.3 0.3 (278)§ 0.759
FCV (L) 2.1 ± 0.8 2.1 ± 0.8 1.9 ± 0.8 -1.3 (278)§ 0.204
Last spirometry dating > 2 years 92 (32.8%) 80 (31.9%) 12 (41.4%) - 0.303
“Do-not-intubate” order 97 (34.6%) 85 (33.9%) 12 (41.4%) - 0.418
Home medication
Long-action	β-agonist 159 (56.8%) 141 (56.2%) 18 (62.1%) - 0.344
Anticholinergic 128 (45.7%) 117 (46.6%) 11 (37.9%) - 0.246
Inhaled corticosteroid 137 (48.9%) 122 (48.6%) 15 (51.7%) - 0.451
Xantines 81 (28.9%) 71 (28.3%) 10 (34.5%) - 0.309
Systemic corticosteroid 17 (6.1%) 16 (6.4%) 1 (3.4%) - 0.455
Long term oxygen 104 (37.1%) 93 (37.1%) 11 (37.9%) - 0.538
Admission clinical status
Glasgow come scale < 15 61 (21.8%) 56 (22.3%) 5 (17.2%) - 0.531
Systolic blood pressure (mm Hg) 130.0 ± 26.0 13.1 ± 26.0 120.0 ± 28.0 2.0 (33.9)‡ 0.048
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Results
The inclusion criteria were met in 312 cases. Document-
ed	spirometric	evidence	of	airway	flow	resistance	was	not	
found in 15 cases and 17 cases had a concurrent diagnosis 
at admission (Fig. 1). The remaining 280 cases were en-
rolled in the study. The mean age of the patients was 76.0 
± 10.0 years, and 53.6% were male participants. Tables 1 
and 2 show the characteristics of the patient sample. De-
pressed mental status was evident in 21.8% and hypoten-
sion in 3.6%. Thirty six percent were acidemic and 64.3% 
were hypercapnic. Of the seven complications (2.5%) en-
countered,	five	(1.8%)	were	nosocomial	pneumonia	and	two	
(0.7%) were acute pulmonary edema. Respiratory failure 
aggravation lead to 10 critical care unit admissions (3.6%). 
Twenty nine patients died (10.4%). The 48-hour mortality 
was 2.9% (eight patients) and 7-day mortality 6.1% (17 pa-
tients).	Uremia,	glicemia,	 ionogram	were	excluded	due	 to	
frequent missing values.
Respiratory rate (per minute) 26.0 ± 6.3 25.9 ± 6.1 27.2 ± 7.0 1.1 (278)§ 0.278
Temperature (ºC) 36.9 ± 0.5 36.8 ± 0.6 36.9 ± 0.7 0.8 (278)§ 0.406
Admission ABG
pH 7.37 ± 0.9 7.37 ± 0.1 7.35 ± 0.1 1.2 (34.6)‡ 0.250
pCO2 (mm Hg) 56.1 ± 18.6 56.2 ± 18.7 54.9 ± 18.5 0.4 (278)§ 0.712
pO2-fiO2	ratio 240.5 ± 77.1 239 ± 73.0 245 ± 105.0 -0.3 (31.2)‡ 0.790
Bicarbonate	(mmol/L) 29.1 ± 6.3 29.0 ± 6.0 30.0 ± 6.5 0.8 (278)§ 0.400
Lactate	(mmol/L) 1.5 ± 1,3 1.4 ± 1.2 1.8 ± 1.8 -1.0 (32.6)‡ 0.249
Admission lab work 
Leucocyte	count	(10^9/L) 12.0 ± 5.3 12.0 ± 5.2 11.4 ± 6.2 0.5 (32.9)‡ 0.608
Neutrophil	count	(10^9/L) 9.6 ± 5.1 9.7 ± 5.1 8.8 ± 4.8 0.8 (35.5)‡ 0.389
Lymphocyte	count	(10^9/L) 1.5 ± 1.6 1.4 ± 1.1 1.9 ± 3.7 -0.7 (28.5)‡ 0.475
Neutrophil-lymphocyte ratio 11.5 ± 11.7 11.4 ± 11.1 12.2 ± 15.9 -0.3 (31.3)‡ 0.786
Eosinophil	count	(10^9/L) 0.9 ± 0.8 1.1 ± 0.8 0.7 ± 0.5 2.5 (47.0)‡ 0.013
Hemoglobin	(g/dL) 13.5 ± 1.9 13.5 ± 1.9 12.7 ± 2.3 2.1 (278)§ 0.041
Hematocrit 41.3 ± 6.3 41.5 ± 6.1 38.6 ± 7.2 2.5 (278)§ 0.041
RDW 15.5 ± 2.3 15.5 ± 2.4 15.6 ± 1.6 0.3 (278)§ 0.794
Creatinine	(mg/dL) 1.17 ± 0.4 1.1 ± 0.4 1.3 ± 0.6 -2.1 (278)§ 0.035
C	reactive	protein	(mg/L) 86.3 ± 89.0 85.1 ± 95.1 96.4 ± 121 -0.5 (32.0)‡ 0.631
Atrial	fibrillation	on	ECG 30 (10.7%) 21 (8.4%) 9 (31.0%) - <0.001
Pseudomonas aeruginosa isolation 5 (1.7%) 4 (1.6%) 1 (3,4%) - 0.524
Other MRM isolation 3 (1.1%) 3 (1,2%) 0 (0.0%) - 0.554
*Continuous	variables	presented	as	mean	±	standard	deviation	and	categorical	variables	as	count	(frequency	%).	†	2-tailed	significance	of	the	t	test	for	con-
tinuous variables or Fisher exact test for categorical variables. ‡ Welch-Satterthaite t test. § Student t test. df - degrees of freedom. FEV1 – forced expiratory 
volume in one second. FVC – forced vital capacity. ABG – arterial blood gasimetry. RDW – red cell distribution width. ECG – electrocardiogram. MRM – multi-
resistant	microorganisms:	methicillin-resistant	Staphylococcus aureus, extended spectrum beta-lactamase Gram negatives
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Comparing survivor and deceased groups, differences 
were	found	in	the	following	parameters	known	at	admission:	
age, hospital admission in the previous 90 days, systolic 
blood pressure, eosinophil count, hemoglobin, hematocrit, 
creatininemia,	 and	 atrial	 fibrillation	 (Table	 1).	 A	more	 fre-
quent requirement for mechanical ventilation, intensive 
care unit admission and a higher rate of complications were 
found in the deceased group. According to the described 
methodology, the following dichotomic variables were in-
cluded in a logistic regression model for in-hospital death 
outcome:	older	than	80	years	(104	cases	–	37.1%),	hospital	
admission in the previous 90 days (16 cases – 5.7%), he-
moglobin	 below	 10.0	 g/dL	 (13	 cases	 –	 4.6%),	 hematocrit	
inferior	to	44%	(13	cases	–	4.6%),	creatinine	above	2.0	mg/






t test (df) p value†
(n = 251) (n = 29)
Hospital therapy
Inhaled bronchodilator 280 (100%) 251 (100%) 29 (100%) - 1.000
Systemic corticosteroid 280 (100%) 251 (100%) 29 (100%) - 1.000
Oxygen 270 (96.4%) 241 (96.0%) 29 (100%) - 0.418
Antibiotic 250 (89.3%) 224 (80.0%) 26 (89.6%) - 0.244
Noninvasive ventilation 119 (42.5%) 102 (40.6%) 17 (58.6%) - 0.050
Invasive mechanical ventilation 11 (3.9%) 7 (2.8%) 4 (13.8%) - 0.018
Vasopressor 1 (0.4%) 1 (0.4%) 0 (0.0 %) - 0.896
Outcomes 
ICU	admission 10 (3.6%) 7 (2.8%) 3 (10.3%) - 0.073
Hospital stay length (days) 7.9 ± 5.0 7.8 ± 4.7 7.9 ± 7.7 -0.1 (30.4)‡ 0.960
Complications 7 (2.5%) 4 (1.6%) 3 (10.3%) - 0.004
In-hospital death 29 (10.4%) - - - -
*Continuous	variables	presented	as	mean	±	standard	deviation	and	categorical	variables	as	count	(frequency	%).	†	2-tailed	significance	of	the	t	test	for	conti-
nuous	variables	or	Fisher	exact	test	for	categorical	variables.	‡	Welch-Satterthaite	t	test.	df	-	degrees	of	freedom.	ICU	–	intensive	care	unit.
Figura 1: Flowchart of patient disposition
312 patients met incluison criteria
Excluded: 
15 patients: no spirometric airflow res-
triction evidence
17 patients: concurrent diagnosis at the 
admission
280 enroled in the study
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dL (17 cases – 6.0%), SBP lower than 100 mm Hg (26 cases 
– 9.3%), eosinophil count higher than 0.5 x 109/L	(57	cases	
– 20.4%), presence of AF (Table 3). Patients showing AF 
at admission were 5.0 times more likely to die in the hos-
pital.	Those	with	hemoglobin	below	10.0	g/dL	 faced	simi-
lar odds. Having a hospital admission in the preceding 90 
days,	creatinine	above	2.0	mg/dL,	SBP	lower	than	100	mm	
Hg or eosinopenia at the admission was associated with 
the in-hospital death outcome in lesser extent. We could 
not	 find	 an	 association	 between	 age	 and	 the	 outcome.	
Hemoglobin and hematocrit produced redundant results. 
The presence of both predictors did not improve the model 
so hematocrit was excluded. The model Nagelkerk R2 was 
0.288.	The	Hosmer	and	Lemeshow	goodness-of-fit	test	had	
Χ2 = 4.2 (5) and p = 0.584. There were no assumptions 
violation and none of the small number of statistical outliers 
significantly	influenced	the	model.	The	area	under	the	ROC	
of	predicted	versus	verified	outcomes	was	0.827.
Finally, a match in accumulation of predictive factors and 
increase of deceased frequency was detected. (Table 4).
Table 3: Predictors of all-cause in-hospital death after logistic regression analysis
Variable Unajusted odds ratio B Wald Chi-square (df) 2-tailed p-value Adjusted odds 
ratio
Atrial	fibrillation 5.8 1.9 12.9 (1) 0.002* 5.0
Admission in the previous 90 days 3.8 1.6 7.9 (1) 0.006* 4.7
Hemoglobin	<	10	g/dL 3.8 1.7 5.1 (1) 0.026* 5.1
Creatinine	>	2.0	mg/dL 4.5 1.4 4.0 (1) 0.048* 3.8
SBP < 100 mm Hg 3.9 1.3 5.1 (1) 0.023* 3.7
Eosinophil	count	<	0.5	x	10^9/L 2.2 1.0 4.7 (1) 0.034* 2.7
Age > 80 years 2.6 0.7 2.91 (1) 0.078 2.2
*p value was statistically reliable. df - degrees of freedom. SBP – systolic blood pressure.
Table 4: Patient distribution according to number of identifiable predictive factors and respective mortality
Number of predictive factors




Cases n (%) Deceased n (%) Cases n (%) Deceased n (%)
0 152 (54.3%) 3 (2.0%) 102 (55.7%) 0 (0.0%)
1 94 (33.6%) 12 (12.8%) 60 (32.8%) 9 (15.0%)
2 29 (10.4%) 11 (37.9%) 15 (8.2%) 5 (33.3%)
3 6 (2.1%) 3 (50.0%) 6 (3.2%) 3 (50.0%)
≥4 0 (0.0%) - 0 (0.0%) -
DNIO – do-not-intubate order.
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Discussion
Our analysis considered patients who were primarily treat-
ed in an Internal Medicine ward and included those with 
‘do-not-intubate’	order	and/or	survival-limitative	comorbid-
ities to better represent the circumstances which internist 
doctors face every day. Comparing our results to similar 
studies,	we	noticed:	our	patients	were	older	and	 the	 fre-
quency of cardiovascular, cerebrovascular and kidney fail-
ure was higher, corresponding a greater comorbidity index 
mean; ambulatory spirometric results were worst; long term 
oxygen prescription was more frequent; a lower frequency 
of	prescribed	β2-agonist	and	systemic	corticosteroid	was	
evident; regarding the clinical status at admission, they 
were more tachycardic and more hypotensive on average; 
higher frequency of acidemic patients, renal dysfunction 
and	 lower	 levels	of	hemoglobin/hematocrit	was	detected;	
even though a greater requirement for mechanical ventila-
tion was observed, the overall all-cause in-hospital mortal-
ity was comparable.5-7
In our patient sample, the factors that most contributed 
to	in-hospital	death	were:	hospital	admission	in	preceding	
90	 days,	 hemoglobin	 below	 10.0	 g/dL,	 creatinine	 above	
2.0	md/dL,	SBP	below	100	mm	Hg,	eosinophil	count	lower	
than	0.5	x	109/L	and	presence	of	AF.
The concomitant presence of COPD and cardiac ar-
rhythmia, including AF, is common and several architectur-
al and electrophysiological changes are known to occur in 
the right heart of COPD patients.8 Some authors conclud-
ed that reduced lung function is an independent predictor 
for incident AF and appointed hypoxia and cor pulmonale 
as physiopathologic intermediaries to some extent.9 Like-
wise, the manifestation of AF may heighten the oxygen 
demand	in	a	hypoxic/acidemic	status	of	COPD	exacerba-
tion leading to further cardiac function compromise. Fur-
thermore, AF increases the risk of embolization events.10 
These events could justify our results where AF had a direr 
impact	 on	 in-hospital	 outcome.	 Similar	 findings	 were	 re-
ported previously.5 The other cardiovascular parameter 
associated with in-hospital death was systolic blood pres-
sure below 100 mm Hg. Hypotension could be a result of 
a decreased cardiac output derived from a failing left ven-
tricle (acidemia and hypoxia) or from lower venous return 
as the intra-thoracic pressure builds up due to air trapping 
and dyspnea. Intravascular depletion due to tachypnea, 
fever or iatrogenic diuresis could also result in hypoten-
sion.	Analogous	findings	were	attested	by	other	authors.11
Being ubiquitous as a prognostic marker in several 
chronic diseases, the need for repeated hospital admis-
sions could signal a rapid decline in the patient status, an 
increase	in	disease	severity	and/or	surrounding	comorbid-
ities and an inability to mitigate the symptoms with domicil-
iary therapies.2 This supports the admission in the preced-
ing 90 days variable as a negative predictive factor.
Hemoglobin	level	inferior	to	10.0	g/dL	was	the	next	predic-
tive factor found. Indeed, the COPD patients who required 
hospitalization had an increased frequency of anemia as stat-
ed in two 2006 studies.12,13 In another study regarding pa-
tients with respiratory acidosis submitted to noninvasive me-
chanical ventilation, anemia was associated with in-hospital 
death.14 The same conclusion was evident in COPD patients 
admitted to critical care units.4 We hypothesize that anemia 
could diminish the oxygen delivery to vital organs, added 
to	the	burden	of	respiratory	insufficiency.	Moreover,	anemia	
may represent a marker of malnutrition or chronic disease, 
heralding a worst prognosis.
Classic acute phase markers like leukocytosis with neu-
trophilia or elevated C reactive protein did not sign a bad 
outcome. Instead, our data revealed eosinopenia as a 
negative predictive factor. Other studies point to the same 
conclusion.5 The eosinophil count was appointed as a use-
ful marker of severity in patients admitted with an exac-
erbation of COPD leading to more mortality and lengthier 
hospital stay.15	Eosinopenia	was	reported	in	acute	inflam-
mation pathophysiology studies.16 And it can indicate a 
hastened	inflammatory	response	as	shown	in	critical	care	
patients.17 In our analysis, other hematologic markers like 
neutrophil-lymphocyte ratio or red cell distribution width 
could not be associated with patient outcome.
Our results could not correlate the presence of acidem-
ia or hypercapnia with a worst outcome. In investigations 
considering	 exclusively	 ‘do-not-intubate’	 order	 patients,	
pH level alone was also incapable of predicting in-hospital 
death.18 But some authors suggest these markers as a se-
verity factor leading to this outcome.5 More recent studies 
signal compensatory mechanisms impairment as the un-
derlying aggravating factor and not the acidemia per se, 
and those patients require more ventilation support and 
had worst outcome.19 An important compensatory mecha-
nism lies in kidney bicarbonate production. Indeed, our re-
sults indicate kidney failure herald a worst prognosis. Oth-
er	studies	pointed	similar	findings.11 The renal impairment 
can debilitate the bicarbonate production and deteriorate 
the excretion of acidic compounds, producing metabolic 
acidosis in addition to respiratory acidosis and leading to 
an even more unfavorable outcome.19 Critical respiratory 
acidosis at admission may had hasten mechanical ven-
tilation (invasive or noninvasive) justifying the similitude 
between the groups as is ground knowledge that type 2 
respiratory failure with respiratory acidosis calls for those 
treatments.20,21 The same can be applied to results con-
cerning the depressed level of consciousness. So, consid-
ering the in-hospital death outcome, pharmacologic and 
ventilatory therapy failure may represent a more adequate 
prognostic marker.
Age was considered an outcome predictor in two studies.5,22 
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In our results, albeit there was a difference between groups, 
an	age-outcome	association	was	not	statically	significant	 in	
the	final	regression	model.	In	regression	intermediary	steps	
that excluded the hemoglobin and creatinine level param-
eters,	age	above	80	years	became	significant.	Therefore,	
age may represent a surrogate marker since anemia and 
renal compromises were more frequent in older patients. A 
higher age could represent a more advanced disease and 
greater conjunction of comorbidities.
Parameter´s odds ratio presented by the regression 
analysis varied from 2.0 to 5.1 suggesting a high degree of 
association with the outcome. Furthermore, the ROC curve 
also points an important link between expected and veri-
fied	outcome,	and	the	mortality	raised	according	to	predic-
tors accumulation. This knowledge could assist in distin-
guishing	low/high	risk	patients	at	the	time	of	the	admission.	
We can conjecture the usefulness of repeated parameter 
evaluation during the hospital stay as a pathophysiologic 
assessment	tool.	Moreover,	identified	parameters,	like	low	
blood pressure, low hemoglobin level, renal dysfunction 
or AF presence, may represent intervention targets in the 
COPD exacerbation management alongside respiratory 
dysfunction focused therapies.
We recognize certain limitations adding to the retrospec-
tive nature of the study. The patient selection relied on con-
venience sampling and was restricted to Internal Medicine 
ward admissions from the community. This limits results 
generalization to other clinical contexts like ambulatory 
or	 critical	 care	units.	 This	 also	 inhibits	 the	usage	as	out/
inpatient selection criteria. Certain parameters that could 
not	be	measured	 in	all	 the	subjects,	 justified	by	different	
attending physician criteria or restrains due to institution 
policies, and were not included in the analysis. Some 
could, hypothetically, strengthen the prediction model. 





characteristics as they tend to be older and to have more 
comorbidities.	We	 found	adverse	outcome	predictors:	ad-
mission	in	the	preceding	90	days,	cardiovascular	(atrial	fi-
brillation and hypotension), hematologic (eosinopenia and 
anemia) and renal dysfunction. Although these markers do 
not immediately relate to respiratory dysfunction (like hy-
percapnia or acidemia), they can be linked to the COPD ex-
acerbation	pathophysiology.	These	findings	point	toward	a	
multisystem approach, an Internal Medicine hallmark, when 
managing a COPD exacerbation patient with various co-
morbidities. More studies are needed to further understand 
the	 role	 of	 these	 findings	 namely	 in	 severity	 stratification	
and therapeutic guidance.   ■
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